Co-founder & CEO, Cannabics Pharmaceuticals
Eyal took the helm of Cannabics in January. The company is based in Maryland but is licensed by the Israeli government to conduct research and development at its facility in Rehovot, Israel. Eyal has experience in the Israel market, having earned degrees from Hebrew University in Jerusalem and Haifa University. Before joining Cannabics, he spent 13 years as CEO of a digital media company and also has worked with big data and artificial intelligence.